Continuous glucose monitoring adoption in the United Kingdom - an economic and policy perspective
File(s)EU ENDO 13.2_073-5_0.pdf (55.58 KB)
Published version
Author(s)
Oliver, N
Type
Journal Article
Abstract
Continuous glucose monitoring (CGM) technology provides real-time glucose concentration data to people with diabetes. The data enable timely treatment decisions that can lead to avoidance or mitigation of hypoglycaemia, with potential cost savings. This commentary discusses CGM implementation and funding policies in the UK, and regional disparities that confront many people with diabetes who could benefit from the technology.
Date Issued
2017-08-22
Date Acceptance
2017-08-01
Citation
European Endocrinology, 2017, 13 (2), pp.73-75
ISSN
1758-3772
Publisher
Touch Medical Media
Start Page
73
End Page
75
Journal / Book Title
European Endocrinology
Volume
13
Issue
2
Copyright Statement
© Touch Medical Media. This article is published under the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, distribution, adaptation and reproduction provided the original.
Publication Status
Published
Date Publish Online
2017-08-22